Fremanezumab

Fremanezumab Effective in Reversion of Chronic Migraine to Episodic Migraine

Fremanezumab Effective in Reversion of Chronic Migraine to Episodic Migraine

By

This Phase III, multicenter, double-blind study sought to explore the effect of fremanezumab on the potential reversion from chronic migraine to episodic migraine.

Fremanezumab May Help Reduce Medication Overuse in Chronic Migraine

Fremanezumab May Help Reduce Medication Overuse in Chronic Migraine

By

Treatment with fremanezumab may help reduce medication overuse and the number of days of acute medication use in individuals with chronic migraine.

Fremanezumab Reduces Monthly Migraine Days in Chronic Migraine

Fremanezumab Reduces Monthly Migraine Days in Chronic Migraine

By

Fremanezumab has shown efficacy in safely reducing monthly headache days in individuals with chronic migraine.

Biologics License Application Submitted for Fremanezumab for Migraine Prevention

Biologics License Application Submitted for Fremanezumab for Migraine Prevention

By

Teva announced the submission of a Biologics License Application to the FDA for fremanezumab for the prevention of migraine.

Sign Up for Free e-Newsletters